Steven Cohen's BIOA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 41,180 shares of BioAge Labs, Inc. (BIOA) worth $544,811, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in BIOA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 41,180 shares. Largest reduction occurred in Q4 2024, reducing 2,700 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's BioAge Labs (BIOA) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioAge Labs (BIOA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +41,180 | New Buy | 41,180 | $13.23 |
| Q4 2024 | -2,700 | Sold Out | 0 | $0.00 |
| Q3 2024 | +2,700 | New Buy | 2,700 | $20.80 |
Steven Cohen's BioAge Labs Investment FAQs
Steven Cohen first purchased BioAge Labs, Inc. (BIOA) in Q3 2024, acquiring 2,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held BioAge Labs, Inc. (BIOA) for 3 quarters since Q3 2024.
Steven Cohen's largest addition to BioAge Labs, Inc. (BIOA) was in Q4 2025, adding 41,180 shares worth $544,811.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 41,180 shares of BioAge Labs, Inc. (BIOA), valued at approximately $544,811.
As of the Q4 2025 filing, BioAge Labs, Inc. (BIOA) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in BioAge Labs, Inc. (BIOA) was 41,180 shares, as reported at the end of Q4 2025.